Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Pediatrics
Published in: World Journal of Pediatrics 2/2021

01-04-2021 | Pharyngitis | Letter to Editor

Prevalence and characteristics of Kawasaki disease before and during the COVID-19 pandemic

Authors: Rintaro Ono, Daisuke Hasegawa

Published in: World Journal of Pediatrics | Issue 2/2021

Login to get access

Excerpt

Kawasaki disease (KD) is a febrile disease with unclear pathogenesis. Thus far, KD has been considered to be triggered, at least in part, by an infection [1]. In 2020, coronavirus disease 2019 (COVID-19) became a global pandemic and lifestyles changed drastically. Consequently, the prevalence of common infection has decreased significantly. This epidemiological change prompted us to postulate that major variations of common pediatric infections would affect the incidence of KD. …
Literature
1.
Rowley AH, Wylie KM, Kim KY, Pink AJ, Yang A, Reindel R, et al. The transcriptional profile of coronary arteritis in Kawasaki disease. BMC Genomics. 2015;16:1076.CrossRef
2.
Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 2005;47:232–4.CrossRef
3.
Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379:1613–20.CrossRef
4.
Ono R, Shimizu M, Yamamoto K, Umehara N, Manabe A. Kawasaki disease shock syndrome: case report and cytokine profiling. Pediatr Int. 2019;61:620–2.CrossRef
5.
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347–58.CrossRef
6.
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334–46.CrossRef
7.
Metadata
Title
Prevalence and characteristics of Kawasaki disease before and during the COVID-19 pandemic
Authors
Rintaro Ono
Daisuke Hasegawa
Publication date
01-04-2021
Publisher
Springer Singapore
Published in
World Journal of Pediatrics / Issue 2/2021
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-021-00412-5

Other articles of this Issue 2/2021

World Journal of Pediatrics 2/2021 Go to the issue

Meta-analysis

Association of neonatal blood levels of brain-derived neurotrophic factor with development of autism spectrum disorder: a systematic review and meta-analysis

Personal Viewpoint

Sleep in children with eosinophilic esophagitis

Review Article

Reducing neonatal mortality and respiratory distress syndrome associated with preterm birth: a scoping review on the impact of antenatal corticosteroids in low- and middle-income countries

Review Article

Immunopathogenesis of idiopathic nephrotic syndrome in children: two sides of the coin

Original Article

Prevalence of Epstein–Barr virus infection and characteristics of lymphocyte subsets in newly onset juvenile dermatomyositis

Original Article

Effects of SARS-CoV-2 infection on neuroimaging and neurobehavior in neonates